CLSD - Clearside Biomedical, Inc.
0.8588
0.010 1.129%
Share volume: 77,862
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.85
0.01
0.01%
Summary score
31%
Profitability
25%
Dept financing
15%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-45.68%
Return on assets
-24.21%
Return on sales
0%
Return on invested capital
146.45%
Total debt ratio
39.34%
Debt ratio change over timeo
0%
Current Ratio
6.37%
Quick Ratio
0%
Cash Position Ratio
3.2%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-50.39%
Return on assets
-19.63%
Return on sales
0%
Return on invested capital
51%
Total debt ratio
59.46%
Debt ratio change over timeo
0%
Current Ratio
2%
Quick Ratio
0%
Cash Position Ratio
1.83%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-78.96%
Return on assets
-31.33%
Return on sales
0%
Return on invested capital
74.42%
Total debt ratio
58.92%
Debt ratio change over time
0%
Current Ratio
1.77%
Quick Ratio
0%
Cash Position Ratio
1.64%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | CLSD | LLY | JNJ | NVO |
---|---|---|---|---|
Return on equity | -45.68% | 17.45% | 4.69% | 19.89% |
Return on assets | -24.21% | 3.37% | 3.35% | 11.41% |
Return on sales | 0% | 23.96% | 25.96% | 42.05% |
Return on invested capital | 146.45% | 5.2% | 4.37% | -272.99% |
Profitability | 25% | 44% | 29% | 75% |
Total debt ratio | 39.34% | 77% | 57.66% | 53.92% |
Debt ratio change over time | 0% | 0% | 10.55% | 0% |
Dept financing | 13% | 25% | 44% | 18% |
Current Ratio | 2% | 1.16% | 1.27% | 1.05% |
Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
Cash Position Ratio | 1.83% | 0.17% | 0.53% | 0.31% |
Liquididy | 50% | 27% | 36% | 23% |
Short-term ratios | CLSD | LLY | JNJ | NVO |
---|---|---|---|---|
Return on equity | -50.39% | 44.06% | 6.24% | 17.3% |
Return on assets | -19.63% | 3.88% | 3.22% | 9.33% |
Return on sales | 0% | 27.04% | 24.93% | 40.02% |
Return on invested capital | 51% | 9.69% | 4.96% | -224.06% |
Profitability | 25% | 57% | 30% | 60% |
Total debt ratio | 59.46% | 91.8% | 61.39% | 55.88% |
Debt ratio change over time | 0% | 0% | 12.93% | 0% |
Dept financing | 16% | 25% | 42% | 15% |
Current Ratio | 2% | 1.16% | 1.27% | 1.05% |
Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
Cash Position Ratio | 1.83% | 0.17% | 0.53% | 0.31% |
Liquididy | 50% | 39% | 48% | 36% |